HS
CBAY
HighVista Strategies’s Cymabay Therapeutics CBAY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-160,334
| Closed | -$3.79M | – | 162 |
|
|
2023
Q4 | $3.79M | Sell |
160,334
-19,971
| -11% | -$472K | 1.37% | 20 |
|
|
2023
Q3 | $2.69M | Sell |
180,305
-158,537
| -47% | -$2.36M | 1.24% | 22 |
|
|
2023
Q2 | $3.71M | Sell |
338,842
-8,944
| -3% | -$97.9K | 1.7% | 8 |
|
|
2023
Q1 | $3.03M | Sell |
347,786
-47,546
| -12% | -$415K | 2.47% | 9 |
|
|
2022
Q4 | $2.48M | Hold |
395,332
| – | – | 1.47% | 21 |
|
|
2022
Q3 | $1.38M | Hold |
395,332
| – | – | 0.79% | 35 |
|
|
2022
Q2 | $1.17M | Buy |
395,332
+188,025
| +91% | +$555K | 0.7% | 34 |
|
|
2022
Q1 | $645K | Buy |
+207,307
| New | +$645K | 0.41% | 63 |
|
|
2021
Q1 | – | Sell |
-116,519
| Closed | -$669K | – | 147 |
|
|
2020
Q4 | $669K | Buy |
+116,519
| New | +$669K | 0.43% | 57 |
|